PMN-442

N/A

Report date: 2022/05/16 15:04:00

Base Information

Drug NamePMN-442
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionSynuclein alpha inhibitors
TargetsSynuclein alpha
Therapy Area/IndicationsDyskinesiasParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesProMIS Neurosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesProMIS Neurosciences Inc
Inactive CompaniesN/A
Active IndicationsDyskinesiasParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A